Reports


Global Pulmonary Arterial Hypertension Treatment Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI235875
  • May 03, 2019
  • Global
  • 96 pages
  • QY Market Research
                                              "The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Pulmonary Arterial Hypertension Treatment market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Pulmonary Arterial Hypertension Treatment market."
Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle cell function- eventually elevating pressure in the pulmonary arteries responsible for pumping blood to the lungs. This eventually leads to right heart failure and, ultimately, death.

The global Pulmonary Arterial Hypertension Treatment market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pulmonary Arterial Hypertension Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Arterial Hypertension Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline plc
    Eli Lilly and Company
    Pfizer Inc.Actelion Inc
    United Therapeutic Corporation
    SteadyMed Ltd
    Gilead Sciences, Inc
    Teva Pharmaceuticals Inc
    Bayer AG

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Vasodilators
    Phosphodiesterase 5 (PDE 5) Inhibitors
    Endothelin Receptor Antagonists (ERA)
    Soluble Guanylate Cyclase (SGC) Stimulator

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
 

Table of Contents

Executive Summary
1 Pulmonary Arterial Hypertension Treatment Market Overview
    1.1 Product Overview and Scope of Pulmonary Arterial Hypertension Treatment
    1.2 Pulmonary Arterial Hypertension Treatment Segment by Type
        1.2.1 Global Pulmonary Arterial Hypertension Treatment Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Vasodilators
        1.2.3 Phosphodiesterase 5 (PDE 5) Inhibitors
        1.2.4 Endothelin Receptor Antagonists (ERA)
        1.2.5 Soluble Guanylate Cyclase (SGC) Stimulator
    1.3 Pulmonary Arterial Hypertension Treatment Segment by Application
        1.3.1 Pulmonary Arterial Hypertension Treatment Consumption Comparison by Application (2014-2025)
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Pulmonary Arterial Hypertension Treatment Market by Region
        1.4.1 Global Pulmonary Arterial Hypertension Treatment Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Pulmonary Arterial Hypertension Treatment Market Size
        1.5.1 Global Pulmonary Arterial Hypertension Treatment Revenue (2014-2025)
        1.5.2 Global Pulmonary Arterial Hypertension Treatment Production (2014-2025)

2 Global Pulmonary Arterial Hypertension Treatment Market Competition by Manufacturers
    2.1 Global Pulmonary Arterial Hypertension Treatment Production Market Share by Manufacturers (2014-2019)
    2.2 Global Pulmonary Arterial Hypertension Treatment Revenue Share by Manufacturers (2014-2019)
    2.3 Global Pulmonary Arterial Hypertension Treatment Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Pulmonary Arterial Hypertension Treatment Production Sites, Area Served, Product Types
    2.5 Pulmonary Arterial Hypertension Treatment Market Competitive Situation and Trends
        2.5.1 Pulmonary Arterial Hypertension Treatment Market Concentration Rate
        2.5.2 Pulmonary Arterial Hypertension Treatment Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Pulmonary Arterial Hypertension Treatment Production Market Share by Regions
    3.1 Global Pulmonary Arterial Hypertension Treatment Production Market Share by Regions
    3.2 Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Regions (2014-2019)
   ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form